211 filings
Page 2 of 11
8-K
shk5f 2783w2
6 Sep 23
Departure of Directors or Certain Officers
7:08am
8-K
ceb1r mdl
8 Aug 23
Mersana Therapeutics Announces Second Quarter 2023 Financial Results
8:04am
8-K
5d0yr6v690tbuy
27 Jul 23
Results of Operations and Financial Condition
7:32am
8-K
lrmgw5y6jw7 89
15 Jun 23
Mersana Therapeutics Announces Partial Clinical Hold on UP-NEXT and UPGRADE-A Clinical Trials
7:38am
8-K
7irekk3u2a
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:25pm
S-3ASR
ele 6pahg7
9 May 23
Automatic shelf registration
4:10pm
8-K
v99a9qv6avwvm tpg
9 May 23
Mersana Therapeutics Provides Business Update and Announces First Quarter 2023 Financial Results
7:11am
ARS
3pa2dfa73t
28 Apr 23
Annual report to shareholders
6:04am
DEFA14A
u31wgzcja5hd 5k7gez2
28 Apr 23
Additional proxy soliciting materials
6:02am
8-K
b2cppwnrvdmzsv
31 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:11pm
8-K
vj1ijdtznlqt710nk3b
24 Mar 23
Entry into a Material Definitive Agreement
4:12pm
8-K
c2nr537
13 Mar 23
Mersana Therapeutics Provides Statement About SVB
8:01am
S-8
6bci 2akq
28 Feb 23
Registration of securities for employees
4:37pm
8-K
p6lxkffvfnqt1qic0pi7
28 Feb 23
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2022 Financial Results
7:17am
8-K
awgpd
1 Feb 23
Company plans to report interim data for the combination of UpRi with carboplatin in the second half of 2023
8:18am